ARC Group Acquisition I Corp wins Nasdaq delisting extension to February 23, 2027

ARC Group Acquisition I Corp received a letter from The Nasdaq Stock Market on October 20, 2026, granting an extension until February 23, 2027, to regain compliance with continued listing rules for its warrants. The extension follows the company's timely submission of a compliance plan on October 12, 2026, in response to a prior notice of non-compliance.

The Nasdaq Listing Qualifications Department issued the initial written notice on August 27, 2026, determining that the aggregate market value of the company's outstanding warrants had fallen below $1 million. This threshold breach violated Nasdaq Listing Rule 5452(b)(C), which mandates that warrants maintain an aggregate market value of at least $1 million. The notice provided the company with 45 calendar days to submit a plan to cure the deficiency.

ARC Group Acquisition I Corp is incorporated in the British Virgin Islands and operates as an emerging growth company. Its securities are registered with the Securities and Exchange Commission under Commission File Number 001-43253. The company's principal executive offices are located at 398 S Mill Avenue, Suite 306, Tempe, AZ 85284. The registrant's Class A ordinary shares trade on The Nasdaq Stock Market LLC under the ticker ARCL, while its units, rights, and warrants trade under ARCLU, ARCLR, and ARCLW, respectively.

Each unit consists of one Class A ordinary share with a par value of $0.0001 per share, one warrant, and one right to acquire one-fourth of a Class A ordinary share. The warrants are exercisable for one Class A ordinary share at an exercise price of $11.50 per share. If the company fails to satisfy the terms of the listing rule by the extended deadline of February 23, 2027, Nasdaq staff will issue written notification that its securities will be delisted. At that point, the company retains the right to appeal the staff's determination to a Listing Qualifications Panel.

The company stated in its filing that it expects to consummate its previously announced business combination before the February 23, 2027 deadline. Management plans to use this period to regain full compliance with the rule. The report was signed by Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Director, on October 22, 2026.